162 related articles for article (PubMed ID: 25486290)
1. Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial).
Vis JY; van Baaren GJ; Wilms FF; Oudijk MA; Kwee A; Porath MM; Scheepers HC; Spaanderman ME; Bloemenkamp KW; van Lith JM; Bolte AC; Bax CJ; Cornette J; Duvekot JJ; Nij Bijvank SW; van Eyck J; Franssen MT; Sollie KM; Woiski M; Vandenbussche FP; van der Post JA; Bossuyt PM; Opmeer BC; Mol BW
Am J Perinatol; 2015 Apr; 32(5):451-60. PubMed ID: 25486290
[TBL] [Abstract][Full Text] [Related]
2. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.
Nijman TA; van Vliet EO; Naaktgeboren CA; Oude Rengerink K; de Lange TS; Bax CJ; Bloemenkamp KW; van Eyck J; Kok M; Scheepers HC; Woiski M; Franx A; Mol BW; Oudijk MA
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():79-84. PubMed ID: 27567363
[TBL] [Abstract][Full Text] [Related]
3. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial).
Vis JY; Wilms FF; Oudijk MA; Porath MM; Scheepers HC; Bloemenkamp KW; Bolte AC; Cornette J; Derks JB; Duvekot JJ; van Eyck J; Kwee A; Opmeer BC; van Pampus MG; Lotgering FK; Scherjon SA; Sollie KM; Spaanderman ME; Willekes C; van der Post JA; Mol BW
BMC Pregnancy Childbirth; 2009 Sep; 9():38. PubMed ID: 19723320
[TBL] [Abstract][Full Text] [Related]
5. Impact of a randomized trial on maintenance tocolysis on length of hospital admission of women with threatened preterm labor in The Netherlands.
Lange TS; Roos C; Bloemenkamp KW; Bolte AC; Duvekot JJ; Franssen MT; Kok M; Oudijk MA; Porath MM; van der Post JA; Mol BW
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():8-11. PubMed ID: 25596476
[TBL] [Abstract][Full Text] [Related]
6. Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial.
Roos C; Spaanderman ME; Schuit E; Bloemenkamp KW; Bolte AC; Cornette J; Duvekot JJ; van Eyck J; Franssen MT; de Groot CJ; Kok JH; Kwee A; Merién A; Nij Bijvank B; Opmeer BC; Oudijk MA; van Pampus MG; Papatsonis DN; Porath MM; Scheepers HC; Scherjon SA; Sollie KM; Vijgen SM; Willekes C; Mol BW; van der Post JA; Lotgering FK;
JAMA; 2013 Jan; 309(1):41-7. PubMed ID: 23280223
[TBL] [Abstract][Full Text] [Related]
7. Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolysis.
Roos C; Vis JY; Scheepers HC; Bloemenkamp KW; Duvekot HJ; van Eyck J; de Groot C; Kok JH; Opmeer BC; Oudijk MA; Papatsonis DN; Porath MM; Sollie K; Spaanderman ME; Lotgering FK; van der Post JA; Mol BW
J Matern Fetal Neonatal Med; 2016; 29(10):1556-61. PubMed ID: 26103778
[TBL] [Abstract][Full Text] [Related]
8. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a cervical pessary for women who did not deliver 48 h after threatened preterm labor (Assessment of perinatal outcome after specific treatment in early labor: Apostel VI trial).
Hermans FJ; Schuit E; Opmeer BC; Oudijk MA; Bekker M; Woiski M; Bax CJ; Sueters M; Scheepers HC; Franssen MT; Pajkrt E; Mol BW; Kok M
BMC Pregnancy Childbirth; 2016 Jul; 16(1):154. PubMed ID: 27405353
[TBL] [Abstract][Full Text] [Related]
10. Effect of maintenance tocolysis with nifedipine in established preterm labour on pregnancy prolongation and neonatal outcome.
Aggarwal A; Bagga R; Girish B; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Feb; 38(2):177-184. PubMed ID: 28784001
[TBL] [Abstract][Full Text] [Related]
11. Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial).
Roos C; Scheepers LH; Bloemenkamp KW; Bolte A; Cornette J; Derks JB; Duvekot HJ; van Eyck J; Kok JH; Kwee A; Merién A; Opmeer BC; van Pampus MG; Papatsonis DN; Porath MM; van der Post JA; Scherjon SA; Sollie K; Spaanderman ME; Vijgen SM; Willekes C; Mol BW; Lotgering FK
BMC Pregnancy Childbirth; 2009 Sep; 9():42. PubMed ID: 19737426
[TBL] [Abstract][Full Text] [Related]
12. Tocolysis in the management of preterm prelabor rupture of membranes at 22-33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM).
Lorthe E; Kayem G;
BMC Pregnancy Childbirth; 2021 Sep; 21(1):614. PubMed ID: 34496799
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).
van Vliet EO; Schuit E; Heida KY; Opmeer BC; Kok M; Gyselaers W; Porath MM; Woiski M; Bax CJ; Bloemenkamp KW; Scheepers HC; Jaquemyn Y; van Beek E; Duvekot HJ; Franssen MT; Bijvank BN; Kok JH; Franx A; Mol BW; Oudijk MA
BMC Pregnancy Childbirth; 2014 Mar; 14():93. PubMed ID: 24589124
[TBL] [Abstract][Full Text] [Related]
15. What is the risk of preterm delivery after arrested preterm labor?
Wilms FF; Vis JY; de Wit-Zuurendonk L; Porath MM; Mol BW
Am J Perinatol; 2015 Jan; 32(1):63-70. PubMed ID: 24839150
[TBL] [Abstract][Full Text] [Related]
16. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials.
Berghella V; Saccone G
Am J Obstet Gynecol; 2016 Oct; 215(4):431-8. PubMed ID: 27133012
[TBL] [Abstract][Full Text] [Related]
17. Nifedipine for Acute Tocolysis of Preterm Labor: A Placebo-Controlled Randomized Trial.
Hawkins JS; Wells CE; Casey BM; McIntire DD; Leveno KJ
Obstet Gynecol; 2021 Jul; 138(1):73-78. PubMed ID: 34259466
[TBL] [Abstract][Full Text] [Related]
18. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial.
Papatsonis DN; Van Geijn HP; Adèr HJ; Lange FM; Bleker OP; Dekker GA
Obstet Gynecol; 1997 Aug; 90(2):230-4. PubMed ID: 9241299
[TBL] [Abstract][Full Text] [Related]
19. Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study.
How HY; Zafaranchi L; Stella CL; Recht K; Maxwell RA; Sibai BM; Spinnato JA
Am J Obstet Gynecol; 2006 Apr; 194(4):976-81. PubMed ID: 16580286
[TBL] [Abstract][Full Text] [Related]
20. Maintenance tocolysis with nifedipine in threatened preterm labour: 2-year follow up of the offspring in the APOSTEL II trial.
van Vliet E; Seinen L; Roos C; Schuit E; Scheepers H; Bloemenkamp K; Duvekot JJ; van Eyck J; Kok JH; Lotgering FK; van Baar A; van Wassenaer-Leemhuis AG; Franssen MT; Porath MM; van der Post J; Franx A; Mol B; Oudijk MA
BJOG; 2016 Jun; 123(7):1107-14. PubMed ID: 26330379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
